WF
Wayfinding Financial, LLC
13F filer · CIK 0001898131Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$264MU.S. long equity reported on 13F
Positions11814 new · 5 closed
Net flow last quarter+$3.06MBuys minus sells
Top 10 positions weight25.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 2026118 positions | |||||
| $16.9M | 6.39% | 0.00% | -2.3% | Q4 2021 | |
| $14.4M | 5.44% | 0.00% | +0.4% | Q4 2021 | |
| $10.9M | 4.15% | 0.00% | +1.0% | Q4 2021 | |
| $6.47M | 2.45% | 0.09% | -1.0% | Q2 2025 | |
| PBPMBSPuramed Bioscience Inc. | $4.31M | 1.63% | 0.04% | +10.9% | Q4 2025 |
| $3.44M | 1.30% | 0.00% | -3.8% | Q4 2021 | |
| $2.76M | 1.04% | 2.56% | +12.1% | Q4 2021 | |
| $2.35M | 0.89% | 0.00% | +0.4% | Q4 2021 | |
| $2.28M | 0.86% | 0.00% | -3.7% | Q4 2021 | |
| $2.14M | 0.81% | 0.00% | +1.1% | Q4 2024 | |
| $1.68M | 0.64% | 0.00% | +1.6% | Q4 2021 | |
| $1.68M | 0.64% | 0.00% | +3.1% | Q4 2021 | |
| $1.65M | 0.63% | 0.00% | +0.2% | Q4 2021 | |
| $1.45M | 0.55% | Not reported | +0.8% | Q4 2021 | |
| $1.42M | 0.54% | 0.00% | -0.2% | Q4 2021 | |
| $1.41M | 0.53% | 0.00% | +1.6% | Q4 2021 | |
| $1.36M | 0.51% | 0.00% | +1.6% | Q4 2024 | |
| $1.36M | 0.51% | 0.00% | +1.6% | Q4 2021 | |
| $1.33M | 0.50% | 0.00% | -7.1% | Q4 2021 | |
| $1.31M | 0.50% | 0.00% | -4.2% | Q4 2021 | |
| $1.27M | 0.48% | Not reported | +0.9% | Q4 2021 | |
| $1.22M | 0.46% | 0.00% | -5.2% | Q4 2021 | |
| $1.12M | 0.42% | 0.00% | +1.7% | Q2 2022 | |
| $1.11M | 0.42% | 0.00% | +0.6% | Q4 2024 | |
| $1.04M | 0.39% | 0.00% | +1.9% | Q4 2021 | |
| $1.02M | 0.39% | Not reported | +3.4% | Q4 2021 | |
| $1.01M | 0.38% | 0.00% | +0.6% | Q4 2021 | |
| $993K | 0.38% | Not reported | -28.2% | Q3 2024 | |
| $983K | 0.37% | 0.00% | +20.7% | Q1 2025 | |
| $927K | 0.35% | 0.00% | -4.0% | Q1 2025 | |
| $902K | 0.34% | 0.00% | -4.0% | Q1 2025 | |
| $884K | 0.33% | 0.00% | +0.1% | Q4 2021 | |
| $815K | 0.31% | 0.00% | -4.9% | Q4 2021 | |
| $805K | 0.30% | 0.00% | +1.4% | Q4 2021 | |
| $803K | 0.30% | 0.00% | -1.4% | Q4 2021 | |
| $767K | 0.29% | 0.00% | -3.0% | Q4 2021 | |
| $748K | 0.28% | 0.00% | +0.7% | Q4 2021 | |
| $701K | 0.27% | 0.00% | +5.7% | Q4 2021 | |
| $698K | 0.26% | 0.00% | -2.2% | Q4 2024 | |
| $685K | 0.26% | 0.00% | +10.5% | Q4 2024 | |
| $620K | 0.23% | 0.00% | -3.0% | Q4 2021 | |
| $615K | 0.23% | 0.00% | +0.8% | Q4 2024 | |
| $604K | 0.23% | 0.00% | +2.0% | Q3 2022 | |
| $563K | 0.21% | 0.00% | +6.3% | Q4 2021 | |
| $554K | 0.21% | 0.00% | +1.2% | Q4 2024 | |
| $534K | 0.20% | 0.00% | +3.0% | Q4 2024 | |
| $522K | 0.20% | 0.00% | +5.1% | Q4 2021 | |
| $509K | 0.19% | 0.00% | -2.7% | Q4 2024 | |
| $503K | 0.19% | 0.00% | +0.8% | Q4 2021 | |
| $499K | 0.19% | 0.00% | -19.3% | Q4 2021 | |
| Q1 2026Reported May 12, 2026109 positions | |||||
| $17.1M | 7.44% | 0.00% | -3.5% | Q4 2021 | |
| $12.5M | 5.42% | 0.00% | -1.9% | Q4 2021 | |
| $9.5M | 4.13% | 0.00% | +1.9% | Q4 2021 | |
| $6.08M | 2.64% | 0.09% | +1.8% | Q2 2025 | |
| PBPMBSPuramed Bioscience Inc. | $3.91M | 1.70% | 0.04% | +44.2% | Q4 2025 |
| $3.81M | 1.65% | 0.00% | -3.2% | Q4 2021 | |
| $2.6M | 1.13% | 2.29% | -0.7% | Q4 2021 | |
| $2.05M | 0.89% | 0.00% | +3.8% | Q4 2021 | |
| $1.6M | 0.69% | 0.00% | +5.3% | Q4 2021 | |
| $1.59M | 0.69% | 0.00% | +0.1% | Q4 2021 | |
| $1.57M | 0.68% | 0.00% | +1.3% | Q4 2021 | |
| $1.46M | 0.63% | Not reported | -4.0% | Q4 2021 | |
| $1.31M | 0.57% | 0.00% | +5.8% | Q4 2021 | |
| $1.26M | 0.55% | 0.00% | -1.3% | Q4 2021 | |
| $1.26M | 0.54% | 0.00% | -32.3% | Q4 2021 | |
| $1.25M | 0.54% | Not reported | +1.4% | Q3 2024 | |
| $1.24M | 0.54% | 0.00% | -0.1% | Q4 2021 | |
| $1.23M | 0.54% | 0.00% | -2.5% | Q4 2021 | |
| $1.2M | 0.52% | Not reported | +1.7% | Q4 2021 | |
| $1.14M | 0.50% | 0.00% | +1.5% | Q4 2021 | |
| $1.1M | 0.48% | 0.00% | +2.5% | Q4 2021 | |
| $1.1M | 0.48% | 0.00% | +1.7% | Q4 2024 | |
| $1.01M | 0.44% | 0.00% | +5.3% | Q4 2021 | |
| $1.01M | 0.44% | 0.00% | -1.7% | Q4 2021 | |
| $850K | 0.37% | 0.00% | +4.0% | Q4 2021 | |
| $843K | 0.37% | 0.00% | +3.3% | Q2 2022 | |
| $836K | 0.36% | 0.00% | +3.7% | Q4 2021 | |
| $808K | 0.35% | 0.00% | -1.1% | Q4 2021 | |
| $802K | 0.35% | Not reported | +12.0% | Q4 2021 | |
| $797K | 0.35% | 0.00% | +3.7% | Q4 2021 | |
| $768K | 0.33% | 0.00% | -3.5% | Q4 2021 | |
| $741K | 0.32% | 0.00% | +2.7% | Q4 2024 | |
| $740K | 0.32% | 0.00% | +3.1% | Q4 2021 | |
| $712K | 0.31% | 0.00% | +2.3% | Q4 2021 | |
| $705K | 0.31% | 0.00% | -0.5% | Q4 2024 | |
| $640K | 0.28% | 0.00% | +2.4% | Q4 2021 | |
| $631K | 0.27% | 0.00% | +12.2% | Q4 2024 | |
| $621K | 0.27% | 0.00% | +3.4% | Q4 2021 | |
| $522K | 0.23% | 0.00% | +1.2% | Q3 2022 | |
| $522K | 0.23% | 0.00% | -0.1% | Q4 2021 | |
| $502K | 0.22% | 0.00% | -10.5% | Q4 2021 | |
| $482K | 0.21% | 0.00% | -14.1% | Q4 2021 | |
| $481K | 0.21% | 0.00% | -1.3% | Q4 2021 | |
| $478K | 0.21% | 0.00% | +21.1% | Q4 2021 | |
| $476K | 0.21% | 0.00% | +4.2% | Q1 2025 | |
| $464K | 0.20% | 0.00% | +0.1% | Q4 2021 | |
| $443K | 0.19% | 0.00% | +1.1% | Q4 2024 | |
| $439K | 0.19% | 0.00% | +12.5% | Q4 2024 | |
| $421K | 0.18% | 0.00% | +4.6% | Q4 2024 | |
| $420K | 0.18% | 0.00% | +4.1% | Q4 2021 | |
| Q4 2025Reported Feb 12, 2026104 positions | |||||
| $23.2M | 9.82% | 0.00% | -1.0% | Q4 2021 | |
| $13.6M | 5.76% | 0.00% | +0.4% | Q4 2021 | |
| $9.99M | 4.23% | 0.00% | +1.0% | Q4 2021 | |
| $5.6M | 2.37% | 0.09% | -0.1% | Q2 2025 | |
| $3.41M | 1.44% | 0.00% | -6.4% | Q4 2021 | |
| PBPMBSPuramed Bioscience Inc. | $2.73M | 1.15% | 0.03% | New | Q4 2025 |
| $2.31M | 0.98% | 2.30% | -0.4% | Q4 2021 | |
| $2.19M | 0.93% | 0.00% | -2.2% | Q4 2021 | |
| $1.76M | 0.74% | Not reported | -0.5% | Q4 2021 | |
| $1.74M | 0.74% | 0.00% | -9.7% | Q4 2021 | |
| $1.52M | 0.64% | 0.00% | -1.3% | Q4 2021 | |
| $1.39M | 0.59% | 0.00% | -1.7% | Q4 2021 | |
| $1.36M | 0.58% | 0.00% | -5.9% | Q4 2021 | |
| $1.35M | 0.57% | 0.00% | -3.9% | Q4 2021 | |
| $1.33M | 0.56% | 0.00% | +0.1% | Q4 2021 | |
| $1.28M | 0.54% | 0.00% | -3.2% | Q4 2021 | |
| $1.27M | 0.54% | 0.00% | -0.7% | Q4 2021 | |
| $1.26M | 0.53% | 0.00% | -4.2% | Q4 2021 | |
| $1.24M | 0.53% | Not reported | +1.2% | Q4 2021 | |
| $1.23M | 0.52% | Not reported | +0.8% | Q3 2024 | |
| $1.2M | 0.51% | 0.00% | +1.8% | Q4 2024 | |
| $1.02M | 0.43% | 0.00% | -1.6% | Q4 2021 | |
| $964K | 0.41% | 0.00% | -1.9% | Q4 2021 | |
| $954K | 0.40% | 0.00% | -11.3% | Q2 2022 | |
| $878K | 0.37% | 0.00% | -1.2% | Q4 2021 | |
| $828K | 0.35% | 0.00% | -3.3% | Q4 2021 | |
| $811K | 0.34% | 0.00% | -8.1% | Q4 2021 | |
| $783K | 0.33% | Not reported | +0.7% | Q4 2021 | |
| $764K | 0.32% | 0.00% | -1.9% | Q4 2021 | |
| $759K | 0.32% | 0.00% | +1.3% | Q4 2024 | |
| $751K | 0.32% | 0.00% | -1.9% | Q4 2021 | |
| $709K | 0.30% | 0.00% | -3.8% | Q4 2021 | |
| $697K | 0.30% | 0.00% | -0.5% | Q4 2021 | |
| $691K | 0.29% | 0.00% | -2.2% | Q4 2024 | |
| $685K | 0.29% | 0.00% | -3.1% | Q4 2021 | |
| $684K | 0.29% | 0.00% | -12.0% | Q4 2021 | |
| $681K | 0.29% | 0.00% | +3.9% | Q4 2024 | |
| $681K | 0.29% | 0.00% | +0.1% | Q4 2021 | |
| $599K | 0.25% | 0.00% | -0.2% | Q3 2022 | |
| $570K | 0.24% | 0.00% | -3.1% | Q4 2021 | |
| $566K | 0.24% | 0.00% | -5.9% | Q4 2021 | |
| $559K | 0.24% | 0.00% | -2.9% | Q4 2021 | |
| $548K | 0.23% | 0.00% | -3.0% | Q4 2021 | |
| $451K | 0.19% | 0.00% | -4.5% | Q4 2024 | |
| $443K | 0.19% | 0.00% | -6.1% | Q4 2021 | |
| $418K | 0.18% | 0.00% | -4.9% | Q4 2021 | |
| $410K | 0.17% | 0.00% | +0.7% | Q4 2024 | |
| $405K | 0.17% | 0.00% | +3.1% | Q4 2021 | |
| $402K | 0.17% | 0.00% | -2.2% | Q4 2024 | |
| $387K | 0.16% | 0.00% | +0.3% | Q4 2024 | |
| Q3 2025Reported Nov 14, 2025105 positions | |||||
| $25.1M | 10.79% | 0.00% | -0.1% | Q4 2021 | |
| $13.6M | 5.84% | 0.00% | -0.4% | Q4 2021 | |
| $9.27M | 3.99% | 0.00% | +0.2% | Q4 2021 | |
| $5.26M | 2.26% | 0.09% | +6.2% | Q2 2025 | |
| $3.91M | 1.68% | 0.00% | 0.0% | Q4 2021 | |
| $2.35M | 1.01% | 2.31% | -0.5% | Q4 2021 | |
| $2.13M | 0.92% | 0.00% | -0.2% | Q4 2021 | |
| $1.96M | 0.84% | Not reported | +0.1% | Q4 2021 | |
| $1.94M | 0.83% | 0.00% | +0.2% | Q4 2021 | |
| $1.42M | 0.61% | 0.00% | -0.1% | Q4 2021 | |
| $1.41M | 0.60% | 0.00% | -0.2% | Q4 2021 | |
| $1.37M | 0.59% | 0.00% | Not reported | Q4 2021 | |
| $1.34M | 0.58% | 0.00% | -2.4% | Q4 2021 | |
| $1.23M | 0.53% | Not reported | -1.8% | Q4 2021 | |
| $1.2M | 0.52% | 0.00% | 0.0% | Q4 2021 | |
| $1.19M | 0.51% | 0.00% | -0.9% | Q4 2021 | |
| $1.18M | 0.51% | Not reported | +4.5% | Q3 2024 | |
| $1.13M | 0.49% | 0.00% | 0.0% | Q4 2024 | |
| $1.11M | 0.48% | 0.00% | -0.8% | Q4 2021 | |
| $1.11M | 0.48% | 0.00% | -0.1% | Q4 2021 | |
| $1.09M | 0.47% | 0.00% | -0.1% | Q4 2021 | |
| $1.09M | 0.47% | 0.00% | +0.5% | Q4 2021 | |
| $907K | 0.39% | 0.00% | -0.2% | Q4 2021 | |
| $903K | 0.39% | 0.00% | +1.6% | Q4 2024 | |
| $902K | 0.39% | 0.00% | +0.1% | Q4 2021 | |
| $862K | 0.37% | 0.00% | -0.2% | Q4 2021 | |
| $846K | 0.36% | 0.00% | 0.0% | Q4 2021 | |
| $840K | 0.36% | 0.00% | -0.1% | Q4 2021 | |
| $784K | 0.34% | 0.00% | +0.2% | Q4 2021 | |
| $773K | 0.33% | 0.00% | -0.9% | Q4 2021 | |
| $763K | 0.33% | 0.00% | -1.0% | Q2 2022 | |
| $756K | 0.33% | 0.00% | -1.4% | Q4 2021 | |
| $742K | 0.32% | 0.00% | -0.4% | Q4 2021 | |
| $659K | 0.28% | 0.00% | 0.0% | Q4 2021 | |
| $648K | 0.28% | 0.00% | +4.3% | Q4 2024 | |
| $637K | 0.27% | 0.00% | -0.2% | Q4 2021 | |
| $613K | 0.26% | 0.00% | +0.3% | Q4 2021 | |
| $603K | 0.26% | Not reported | +1.3% | Q4 2021 | |
| $584K | 0.25% | 0.00% | -1.4% | Q3 2022 | |
| $566K | 0.24% | 0.00% | +0.4% | Q4 2024 | |
| $540K | 0.23% | 0.00% | -0.2% | Q4 2021 | |
| $529K | 0.23% | 0.00% | -3.8% | Q4 2021 | |
| $454K | 0.20% | 0.00% | -2.6% | Q4 2021 | |
| $448K | 0.19% | 0.00% | -0.1% | Q4 2024 | |
| $422K | 0.18% | 0.00% | -5.8% | Q4 2021 | |
| $419K | 0.18% | 0.00% | -0.2% | Q4 2024 | |
| $411K | 0.18% | 0.00% | +0.9% | Q4 2024 | |
| $407K | 0.18% | 0.00% | -8.7% | Q4 2024 | |
| $397K | 0.17% | 0.00% | -0.7% | Q4 2021 | |
| $378K | 0.16% | 0.00% | +0.7% | Q4 2021 | |
Premium opens every quarter this fund has filed